Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

Kythera Biopharmaceuticals, Inc. (KYTH)

-NasdaqGS
33.97 Down 0.30(0.88%) Jul 25, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development9,980  9,204  6,969  7,767  
Selling General and Administrative6,121  4,360  4,034  3,973  
Non Recurring52,757   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (68,858) (13,564) (11,003) (11,740)
Income from Continuing Operations
Total Other Income/Expenses Net67  40  32  35  
Earnings Before Interest And Taxes(68,791)(13,524)(10,971)(11,705)
Interest Expense654  494  538  553  
Income Before Tax(69,445)(14,018)(11,509)(12,258)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(69,445)(14,018)(11,509)(12,258)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (69,445) (14,018) (11,509) (12,258)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (69,445) (14,018) (11,509) (12,258)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.